Skip to Content
Merck
CN
  • Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.

Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.

Journal of medicinal chemistry (2007-08-19)
Liqin Zhao, Chunyang Jin, Zisu Mao, Madathil B Gopinathan, Kenneth Rehder, Roberta D Brinton
ABSTRACT

We recently discovered that ICI 182,780 (1), an antagonist of estrogen receptor (ER)-dependent proliferation in reproductive tissues, functions as an estrogenic agonist in primary neurons. The present study investigated whether the agonist properties of 1 in neurons could be translated into structural analogs. 7alpha-[(4R,8R)-4,8,12-trimethyltridecyl]estra-1,3,5-trien-3,17beta-diol (2), a hybrid structure of 17beta-estradiol and vitamin E, was synthesized and found to bind to both ERalpha and ERbeta. In vitro analyses demonstrated that 2 was neuroprotective and effective in activating molecular mechanisms associated with estrogenic agonist activity in rat primary hippocampal neurons. Collectively, the data support an estrogenic agonist profile of 2 action comparable to 1 in primary neurons, confirming that estrogenic activity of 1 in neurons is not a unique phenomenon. These results provide support for the development of a brain-selective ER modulator, with potential as an efficacious and safe estrogen alternative to prevent Alzheimer's disease and cognitive decline in postmenopausal women.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Genistein, synthetic, ≥98% (HPLC), powder
Sigma-Aldrich
Genistein, from Glycine max (soybean), ~98% (HPLC)
Sigma-Aldrich
β-Estradiol, BioReagent, powder, suitable for cell culture
Supelco
Resveratrol, analytical standard
Sigma-Aldrich
β-Estradiol, ≥98%
Sigma-Aldrich
Resveratrol, ≥99% (HPLC)